Metal-Based Nanoparticles: A Prospective Strategy for Helicobacter pylori Treatment
Xiaojing Yin,Yongkang Lai,Yiqi Du,Tinglin Zhang,Jie Gao,Zhaoshen Li
DOI: https://doi.org/10.2147/IJN.S405052
IF: 7.033
2023-05-09
International Journal of Nanomedicine
Abstract:Xiaojing Yin, 1, &ast Yongkang Lai, 1, 2, &ast Yiqi Du, 1, &ast Tinglin Zhang, 3, &ast Jie Gao, 3 Zhaoshen Li 1 1 Department of Gastroenterology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China; 2 Department of Gastroenterology, Ganzhou People's Hospital Affiliated to Nanchang University, Ganzhou, Jiangxi, 341000, People's Republic of China; 3 Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhaoshen Li; Jie Gao, Email ; Helicobacter pylori (H. pylori) is an infectious pathogen and the leading cause of gastrointestinal diseases, including gastric adenocarcinoma. Currently, bismuth quadruple therapy is the recommended first-line treatment, and it is reported to be highly effective, with > 90% eradication rates on a consistent basis. However, the overuse of antibiotics causes H. pylori to become increasingly resistant to antibiotics, making its eradication unlikely in the foreseeable future. Besides, the effect of antibiotic treatments on the gut microbiota also needs to be considered. Therefore, effective, selective, antibiotic-free antibacterial strategies are urgently required. Due to their unique physiochemical properties, such as the release of metal ions, the generation of reactive oxygen species, and photothermal/photodynamic effects, metal-based nanoparticles have attracted a great deal of interest. In this article, we review recent advances in the design, antimicrobial mechanisms and applications of metal-based nanoparticles for the eradication of H. pylori . Additionally, we discuss current challenges in this field and future perspectives that may be used in anti- H. pylori strategies. Keywords: H. pylori , antimicrobial applications, metal based nanoparticles, antibiotic-free, antimicrobial mechanisms Helicobacter pylori ( H. pylori ) is a Gram-negative microaerobic bacterium that colonizes the human stomach. 1–5 Accordingly, it has been associated with gastrointestinal diseases including chronic gastritis, peptic ulcer, gastric carcinoma, and MALT lymphomas. 1–5 In addition, numerous studies have confirmed that H. pylori is closely related to the occurrence and development of such extra-intestinal diseases as idiopathic thrombocytopenic purpura, unexplained iron deficiency anemia and vitamin B12 deficiency. 6 Moreover, there is growing evidence that H. pylori infection is associated with other diseases, particularly relating to cardiovascular, metabolic, and neurological functions. 6 Correspondingly, H. pylori was classified as a Group I carcinogen by the International Agency for Research on Cancer as early as 1994. By the 15th edition of the US Carcinogen Report in 2021, H. pylori was classified as a definite carcinogen. 7 Xie et al indicated that H. pylori can contribute to gastric cancer by inhibiting autophagy and promoting DNA damage. 8–10 In addition, several recent long-term follow-up studies with large samples in regions with a high prevalence of gastric cancer have confirmed the long-term benefits of H. pylori eradication in preventing gastric cancer. 11–13 Although a recent meta-analysis showed that the prevalence of H. pylori in China appears to be on a decreasing trend compared to the past (from 58.3% during 1983–1994 to 40.0% during 2015–2019), 14 it is inevitable that this pathogen will remain increasingly resistant to antibiotics and its infection burden will remain high. 15,16 This necessitates the development of antibiotic alternatives or antibiotic loading systems to mitigate the problem of antibiotic resistance. In recent years, the research and development of antibacterial materials that can replace antibiotics has become an increasingly popular topic. 17–20 Accordingly, nanomaterials have garnered increasing attention in the medical field, particularly due to their significant advantages in drug delivery, as they can administer poorly soluble drugs, protect them from enzymatic reactions, target them to the specific organ to be treated, and diffuse through the biofilm matrix. 21 Among these, metals and their metal oxide nanoparticles (NPs) have attracted increasing research interest due to their unique optical properties, such as surface plasmon resonance (SPR). Moreover, the use of metals as antibacterial agents dates back to the Edwin Smith Papyrus, an ancient Egyptian medic -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology